256 related articles for article (PubMed ID: 36982848)
21. Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan.
Chepanova AA; Zakharenko AL; Dyrkheeva NS; Chernyshova IA; Zakharova OD; Ilina ES; Luzina OA; Salakhutdinov NF; Lavrik OI
Dokl Biochem Biophys; 2023 Feb; 508(1):25-30. PubMed ID: 36653585
[TBL] [Abstract][Full Text] [Related]
22. Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors.
Zhang HL; Zhang Y; Yan XL; Xiao LG; Hu DX; Yu Q; An LK
Bioorg Med Chem; 2020 Jun; 28(11):115527. PubMed ID: 32345458
[TBL] [Abstract][Full Text] [Related]
23. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).
Pommier Y; Huang SY; Gao R; Das BB; Murai J; Marchand C
DNA Repair (Amst); 2014 Jul; 19():114-29. PubMed ID: 24856239
[TBL] [Abstract][Full Text] [Related]
24. Studying TDP1 Function in DNA Repair.
Chiang SC; Liversidge K; El-Khamisy SF
Methods Mol Biol; 2018; 1703():173-181. PubMed ID: 29177742
[TBL] [Abstract][Full Text] [Related]
25. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
Liu C; Pouliot JJ; Nash HA
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14970-5. PubMed ID: 12397185
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel.
Gao R; Das BB; Chatterjee R; Abaan OD; Agama K; Matuo R; Vinson C; Meltzer PS; Pommier Y
DNA Repair (Amst); 2014 Jan; 13():1-9. PubMed ID: 24355542
[TBL] [Abstract][Full Text] [Related]
27. Tyrosyl-DNA phosphodiesterase (Tdp1) (3'-phosphotyrosyl DNA phosphodiesterase).
Raymond AC; Burgin AB
Methods Enzymol; 2006; 409():511-24. PubMed ID: 16793421
[TBL] [Abstract][Full Text] [Related]
28. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
[TBL] [Abstract][Full Text] [Related]
29. N-terminal domain of tyrosyl-DNA phosphodiesterase I regulates topoisomerase I-induced toxicity in cells.
Brettrager EJ; Cuya SM; Tibbs ZE; Zhang J; Falany CN; Aller SG; van Waardenburg RCAM
Sci Rep; 2023 Jan; 13(1):1377. PubMed ID: 36697463
[TBL] [Abstract][Full Text] [Related]
30. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
Dexheimer TS; Gediya LK; Stephen AG; Weidlich I; Antony S; Marchand C; Interthal H; Nicklaus M; Fisher RJ; Njar VC; Pommier Y
J Med Chem; 2009 Nov; 52(22):7122-31. PubMed ID: 19883083
[TBL] [Abstract][Full Text] [Related]
31. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.
Vance JR; Wilson TE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13669-74. PubMed ID: 12368472
[TBL] [Abstract][Full Text] [Related]
32. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
Huang SN; Pommier Y; Marchand C
Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors.
Zakharova O; Luzina O; Zakharenko A; Sokolov D; Filimonov A; Dyrkheeva N; Chepanova A; Ilina E; Ilyina A; Klabenkova K; Chelobanov B; Stetsenko D; Zafar A; Eurtivong C; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
Bioorg Med Chem; 2018 Aug; 26(15):4470-4480. PubMed ID: 30076000
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.
Nguyen TX; Morrell A; Conda-Sheridan M; Marchand C; Agama K; Bermingham A; Bermingam A; Stephen AG; Chergui A; Naumova A; Fisher R; O'Keefe BR; Pommier Y; Cushman M
J Med Chem; 2012 May; 55(9):4457-78. PubMed ID: 22536944
[TBL] [Abstract][Full Text] [Related]
35. New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.
Khomenko TM; Zakharenko AL; Kornienko TE; Chepanova AA; Dyrkheeva NS; Artemova AO; Korchagina DV; Achara C; Curtis A; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298106
[TBL] [Abstract][Full Text] [Related]
36. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.
Comeaux EQ; van Waardenburg RC
Drug Metab Rev; 2014 Nov; 46(4):494-507. PubMed ID: 25327705
[TBL] [Abstract][Full Text] [Related]
37. PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage.
Das BB; Huang SY; Murai J; Rehman I; Amé JC; Sengupta S; Das SK; Majumdar P; Zhang H; Biard D; Majumder HK; Schreiber V; Pommier Y
Nucleic Acids Res; 2014 Apr; 42(7):4435-49. PubMed ID: 24493735
[TBL] [Abstract][Full Text] [Related]
38. TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo.
Katyal S; el-Khamisy SF; Russell HR; Li Y; Ju L; Caldecott KW; McKinnon PJ
EMBO J; 2007 Nov; 26(22):4720-31. PubMed ID: 17914460
[TBL] [Abstract][Full Text] [Related]
39. Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions.
Plo I; Liao ZY; Barceló JM; Kohlhagen G; Caldecott KW; Weinfeld M; Pommier Y
DNA Repair (Amst); 2003 Oct; 2(10):1087-100. PubMed ID: 13679147
[TBL] [Abstract][Full Text] [Related]
40. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.
Zakharenko A; Luzina O; Koval O; Nilov D; Gushchina I; Dyrkheeva N; Švedas V; Salakhutdinov N; Lavrik O
J Nat Prod; 2016 Nov; 79(11):2961-2967. PubMed ID: 27933897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
